Leading through Covid

Despite the challenges of COVID-19, OHG agencies have continued to thrive. We’ve supported nearly a half-dozen new product launches for clients, creating and delivering critical communications support for important healthcare brands. We also formed a cross-agency advisory to identify challenges surrounding remote work, hack problems, and provide work-from-home support for our employees. Our agencies have undertaken and produced several research projects to assess the impact of COVID-19 on the broader healthcare landscape. Click on the links below to see how we’re counseling clients on navigating the pandemic.

Trends in Pharma Marketing Technology Adoption

Trends in Pharma Marketing Technology Adoption

Omnicom Health Group

Contact: Christina Kim

How are pharma companies adopting marketing technology due to the shift from face-to-face engagement to primarily digital communications? What are the opportunities to strengthen digital capabilities that enable a modern healthcare customer engagement? We surveyed advertising organizations in pharma marketing to uncover the current and planned usage of technology in 12 areas of the marketing technology stack.

Read More

 

COVID-19: Unprecedented Catalyst of Digital Health

COVID-19: Unprecedented Catalyst of Digital Health

Omnicom Health Group

Contact: David Madapur

In February, Omnicom Health Group put forth a paper highlighting the technology trends that would shape healthcare in 2020. Since that time, the coronavirus pandemic has altered the world as we knew it and brought our reliance on technology to the fore. Hence we decided to refresh our research and see how COVID-19 affected our predictions and the role the projected digital health trends are playing in the fight against COVID-19.

Read More

Augmenting Sales Force

Augmenting Sales Force

Entrée Health

Contact: Lauren Elliott

If field teams do not have live access to HCP offices at launch, what key strategies do we deploy to effectively reach and increase share of voice quickly? We provide tips and processes on how we can think about activating our sales force teams differently to make the most impact for our brands.

Read More

 

COVID-19: Patient Insights

COVID-19: Patient Insights

SNOW Companies

Contact: Brenda Snow

The world for patients is currently in constant flux, and as such, we need to understand the many challenges patients are facing today and quickly adapt and implement solutions to address their needs. In this document, you’ll read about a survey SNOW companies conducted to learn about how patients are experiencing disruptions in their overall treatment, how they are navigating virtual relationships with their doctors, and much more.

Read More

COVID-19 and Oncology: Adapting to New Realities

COVID-19 and Oncology: Adapting to New Realities

Harrison and Star

Contact: Dan Reed

The purpose of this overview is to show how the practice of oncology is changing during the novel coronavirus (COVID-19) pandemic. Here, we try to anticipate some of the long-term challenges of the pharmaceutical industry and begin to sketch out possible approaches we can take to be relevant and helpful now and in the future.

Read More

 

Social Media Guidance for Brands

Social Media Guidance for Brands

Patients & Purpose

Contact: John Deeley

As the COVID-19 pandemic continues to play out around the world, people in real life are practicing social distancing. But in the virtual world, social media is bringing people closer together in new and inspiring ways. As healthcare brands, it is imperative we consider what our role should be and how to best support our patients in challenging times. Here, we discuss some practical steps we can take to evaluate where your brand is on social today and how we can quickly pivot to be more relevant for our patients during this time.

Read More

Understanding the Informational Needs of HCPs During the COVID-19 Pandemic

Understanding the Informational Needs of HCPs During the COVID-19 Pandemic

SSCG Media

Contact: Sandra Parrelli

When the COVID-19 pandemic started to unfold, and the pharmaceutical industry began grappling with the reality of sales force and live event disruption, conversations sparked around how to fill the void with non-personal promotion. But questions also circulated about ensuring pharma strikes the right level of presence and the right tone with healthcare professionals who are facing immense disruption and uncertainty. So, we went to the source and asked healthcare professionals directly. Our data and findings help fuel recommendations on how to engage with HCPs during these times.

Read More

 

Brand Behavior in the COVID-19 Era

Brand Behavior in the COVID-19 Era

CDM New York

Contact: Kristen Gengaro

CDM conducted an analysis of the collective response to the COVID-19 pandemic, as well as observations of how brands are responding to the global crisis. Based on these observations, we’ve put forth recommendations on how pharmaceutical brands should behave during this crisis and beyond based on the spectrum of human response to COVID-19.

Read More